HIGHLIGHTS
- who: Theerut Luangmonkong and colleagues from the Department of Pharmacology, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand have published the Article: Hepatoprotective Efficacy of Cycloastragenol Alleviated the Progression of Liver Fibrosis in Carbon-Tetrachloride-Treated Mice, in the Journal: Biomedicines 2023, 231 of /2023/
- what: Cycloastragenol at the dosage of 200 mg/kg alleviated the progression of liver fibrosis in CCl4 -treated mice.
SUMMARY
Several attractive pharmacological properties of cycloastragenol which might contribute to the beneficial effects on the liver including hepatoprotective efficacy, antioxidative and anti-inflammatory properties, and telomerase activation . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.